Fc Chimera
Home Up PSA Recombinant Human Vimentin PAG Fc Chimera TRAIL-R1/Fc Chimera TRAIL-R2/Fc Chimera LAB

 

 

Recombinant human DR6 (TNFRSF21)/Fc Chimera

Source:

Produced in HEK 293 cells. The extracellular domain of human DR6 (aa 1 - 212) is fused to the Fc portion of human IgG1.

Description:

Human DR6 (Death Receptor-6; TNFRSF21) is a type I transmembrane protein containing cytoplasmic death domain, member of the TNF receptor superfamily, expressed in most human tissues.
 

Applications:

  • Loading control
    The recombinant human DR6/Fc chimera can be used as a control for anti-human DR6 antibodies in amounts 15-50 ng.
Usage note:
Indicated dilutions are recommended starting points for use of this product. Working concentrations should be determined by the investigator.

Example Data:

DR6 SDS
Fig. 1. SDS-PAGE

Fig.1. SDS-PAGE Electrophoresis of DR6 / Fc recombinant protein (12% separating gel, 6% stacking gel; reducing conditions).
Lane 1 to 5: DR6 / Fc recombinant protein (2000 ng, 1000 ng, 500 ng, 200 ng, 100 ng per lane). Staining with Coomasie Blue.
 

DR6
Fig. 2. Western Blotting

Fig.2. Western blotting of DR6 / Fc recombinant protein. Reducing conditions.
Lane 1 to 4: immunostaining with rabbit polyclonal antibody specific to DR6 (EC). Detection with Goat anti-rabbit / HRP secondary antibody. Amount of DR6 / Fc recombinant protein loaded on each lane: (1) 150 ng, (2) 75 ng, (3) 30 ng, (4) 15 ng per lane.

______________________________________________________________________________________________________________________

Lyophilized RL-003-C050 0.05 mg 390 EUR